Logo
A

Asklepios BioPharmaceutical, Inc. (AskBio)

372 employees

Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Gene Therapy
AAV Manufacturing
Biopharma
Epigenome
Nucleic Acid
Health Care
Adeno-Associated Virus
Molecular Medicine
AAV
Medical Device
Rare Disease
Medical
Doggybone DNA
Manufacturing

Date founded

2001

Funding rounds raised

Total raised

$235M

from 2 investors over 2 rounds

A

Asklepios BioPharmaceutical, Inc. (AskBio) raised $2.7M on September 2, 2020

Investors: Scottish Enterprise

A

Asklepios BioPharmaceutical, Inc. (AskBio) raised $235M on April 11, 2019

Investors: Vida Ventures, LLC

FAQ